Clinical Characteristics and Longitudinal Outcomes of Primary Mycotic Aortic Aneurysms.


Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 27 6 2019
medline: 1 10 2019
entrez: 27 6 2019
Statut: ppublish

Résumé

Medical therapy for mycotic aortic aneurysms (MAA) is almost universally fatal, while surgical and endovascular repair carry high morbidity and mortality. The purpose of this study was to compare outcomes between patients receiving treatment for MAA. Records were obtained and patients with MAA were stratified by intervention: endovascular repair, open surgery, and medical therapy. Primary outcomes were aneurysm-related mortality and survival. Risk-adjusted associations with mortality were assessed using time-to-event analysis. Thirty-eight patients were identified (median age, 67). Twenty-one underwent endovascular repair,10 had open surgery and 7 received medical therapy alone. Overall mortality was 47% (n = 18), with 94% aneurysm related. Median survival was significantly longer in the endovascular group (747.0 [161-1249]) vs open surgery and medical therapy (507.5 [34-806] and 66 [13-146] days, respectively;

Identifiants

pubmed: 31238697
doi: 10.1177/0003319719858784
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-951

Commentaires et corrections

Type : CommentIn

Auteurs

J Michael Cullen (JM)

1 Department of Surgery, University of Virginia, Charlottesville, VA, USA.

Alexander T Booth (AT)

2 School of Medicine, University of Virginia, Charlottesville, VA, USA.

J Hunter Mehaffey (JH)

1 Department of Surgery, University of Virginia, Charlottesville, VA, USA.

Robert B Hawkins (RB)

1 Department of Surgery, University of Virginia, Charlottesville, VA, USA.

Michael Spinosa (M)

1 Department of Surgery, University of Virginia, Charlottesville, VA, USA.

Kenneth J Cherry (KJ)

3 Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.

William P Robinson (WP)

3 Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.

Margaret C Tracci (MC)

3 Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.

John A Kern (JA)

3 Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.

Gilbert R Upchurch (GR)

3 Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA, USA.
4 Department of Surgery, University of Florida, Gainesville, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH